Novo Nordisk's Wegovy Pill Sees Strong Uptake with Over 26,000 Prescriptions in Second Week
Newly launched oral weight-loss drug Wegovy from Novo Nordisk recorded more than 26,000 U.S. prescriptions in its second full week, signaling robust early demand as competition with Eli Lilly intensifies.